Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
128 hedge funds and large institutions have $358M invested in Lumos Pharma, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 18 closing their positions.
242% more call options, than puts
Call options by funds: $49.1M | Put options by funds: $14.3M
147% more capital invested
Capital invested by funds: $145M → $358M (+$213M)
83% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 18
5% more funds holding
Funds holding: 122 → 128 (+6)
22% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$29.8M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$3.38M |
| 3 |
CCI
Columbus Circle Investors
|
+$3.31M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.16M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$3.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$6.98M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.71M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.53M |
| 4 |
Renaissance Technologies
New York
|
-$1.55M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.08M |
LUMO Hedge Fund Activity: Q1 2017 in Review
128 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2017, worth a combined $358M — up 147% from $145M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new LUMO positions and 18 closed out — a net gain of 15 holders — while 28 added to existing stakes and 36 trimmed.
The largest buyer was BlackRock, adding an estimated $29.8M. The largest seller was Millennium Management, cutting an estimated $6.98M.
- 128 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2017, up from 122 in Q4 2016.
- Funds reported $358M of Lumos Pharma, Inc. Common Stock stock for Q1 2017, up 147% quarter-over-quarter.
- 33 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2017 and 18 closed out, a net change of +15 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $29.8M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q1 2017 was Millennium Management, an estimated $6.98M sold.
Based on aggregated 13F filings for Q1 2017.